Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
- Grant of Canadian Patent for OptiMAL®
09 September 2026 - Notice of results
09 September 2026 - Notice of acceptance of patent in Australia
06 August 2026
Investor Alert
Sign up for Investor Alerts »